首页 >
法规速递
-
Page: Overview of the current regulatory testing requirements for medicinal products for human use and opportunities for implementation of the 3Rs - Scientific guideline-2025/2/13
2025-02-14查看详情 > -
Page: Paediatric investigation plans: questions and answers-2025/3/24
2025-03-25查看详情 > -
Document: FertiPro N.V. HSA-containing ART media - Procedural steps and scientific information after initial consultation (archive)-2025/4/24
2025-04-27查看详情 > -
M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver Draft -2025/5/30
2025-06-06查看详情 > -
Document: 2024 AI Observatory report-2025/7/10
2025-07-11查看详情 > -
关于公开征求《药物临床试验利益相关性声明（试行）（征求意见稿）》意见的通知-2025/8/20
2025-08-21查看详情 > -
Page: Patients' and Consumers' Working Party-2025/9/29
2025-09-30查看详情 > -
How to Prepare a Pre-Request for Designation (Pre-RFD)-2025/11/6
2025-11-07查看详情 > -
Document: All languages - Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) - Revision 5-2025/12/5
2025-12-08查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2026/1/15
2026-01-16查看详情 >
